Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Market Place
ABOUT THIS PAGE
70
PharmaCompass offers a list of Bisbentiamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bisbentiamine manufacturer or Bisbentiamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bisbentiamine manufacturer or Bisbentiamine supplier.
PharmaCompass also assists you with knowing the Bisbentiamine API Price utilized in the formulation of products. Bisbentiamine API Price is not always fixed or binding as the Bisbentiamine Price is obtained through a variety of data sources. The Bisbentiamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS-2667-89-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-2667-89-2, including repackagers and relabelers. The FDA regulates CAS-2667-89-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-2667-89-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-2667-89-2 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-2667-89-2 supplier is an individual or a company that provides CAS-2667-89-2 active pharmaceutical ingredient (API) or CAS-2667-89-2 finished formulations upon request. The CAS-2667-89-2 suppliers may include CAS-2667-89-2 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-2667-89-2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CAS-2667-89-2 Drug Master File in Japan (CAS-2667-89-2 JDMF) empowers CAS-2667-89-2 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CAS-2667-89-2 JDMF during the approval evaluation for pharmaceutical products. At the time of CAS-2667-89-2 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CAS-2667-89-2 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CAS-2667-89-2 Drug Master File in Korea (CAS-2667-89-2 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CAS-2667-89-2. The MFDS reviews the CAS-2667-89-2 KDMF as part of the drug registration process and uses the information provided in the CAS-2667-89-2 KDMF to evaluate the safety and efficacy of the drug.
After submitting a CAS-2667-89-2 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CAS-2667-89-2 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CAS-2667-89-2 suppliers with KDMF on PharmaCompass.
CAS-2667-89-2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-2667-89-2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-2667-89-2 GMP manufacturer or CAS-2667-89-2 GMP API supplier for your needs.
A CAS-2667-89-2 CoA (Certificate of Analysis) is a formal document that attests to CAS-2667-89-2's compliance with CAS-2667-89-2 specifications and serves as a tool for batch-level quality control.
CAS-2667-89-2 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-2667-89-2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-2667-89-2 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-2667-89-2 EP), CAS-2667-89-2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-2667-89-2 USP).
